Blood test for early lung cancer detection
Part of Cancer, Lungs & breathing clinical trials.
This study is testing a new blood test that looks for changes in DNA to detect lung cancer early. It's for people with a new lung cancer diagnosis, those with uncertain CT scan results, healthy volunteers, or those with chronic lung problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You can be a newly diagnosed lung cancer patient before starting treatment, someone with unclear results from a low-dose CT scan, a healthy volunteer, or someone with chronic lung disease (like COPD, emphysema, or pneumonia).
- You cannot have had any cancer other than lung cancer.
- You cannot have HIV or hepatitis.
- You cannot have an active autoimmune disease that affects multiple organs (lung-only conditions are okay).
- Pregnant women and people unable to give consent cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test that uses a special light-based method to help identify types of lung cancer. The test looks at tiny particles in your blood to help doctors understand your cancer better.
This study tests a new blood test that looks for lung cancer DNA. It may help find lung cancer early, especially in people at higher risk.
This study is evaluating a blood-based test that might detect lung cancer early, before symptoms appear. Researchers are looking for heavy smokers who have no signs of cancer, as well as those with suspicious lung nodules or confirmed lung cancer, to see if a simple blood draw could help identify cancer sooner.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This trial studies a “cell-free DNA” blood test to help diagnose and guide treatment decisions for early non-small cell lung cancer. It may help doctors tailor care based on genetic signals seen in the blood before and around surgery.
This study tests a simple blood test to find lung cancer early, before symptoms appear. It may help detect cancer sooner, when treatment could be more effective.
Hear when a new Lung Cancer, Non-Small Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.